|
⚲
|
| Keyboard |
| Ranker Philip C
✚
|
|
|---|---|
| CIK # | 0001301582 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001301582] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ranker Philip C | |
| Adhera Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Adhera Therapeutics Inc MRNA
Options to purchase common stock · derivative
|
2018-05-02 | Grant | 200,000 | $0.00 | |
|
Adhera Therapeutics Inc MRNA
Warrants to Purchase Common Stock · derivative
|
2018-04-16 | Grant | 135,000 | $0.00 | |
|
Adhera Therapeutics Inc MRNA
Series E Convertible Preferred Stock · derivative
|
2018-04-16 | Grant | 18 | $5,000.00 | 90,000 |
|
Adhera Therapeutics Inc MRNA
Options to purchase common stock · derivative
|
2018-01-03 | Grant | 3,800 | $0.00 | |
|
Adhera Therapeutics Inc MRNA
Options to purchase common stock · derivative
|
2017-01-03 | Grant | 81,000 | $0.00 | |
|
Adhera Therapeutics Inc MRNA
Options to purchase common stock · derivative
|
2016-11-15 | Grant | 35,000 | $0.00 | |
|
Adhera Therapeutics Inc MRNA
Options to purchase common stock · derivative
|
2016-01-04 | Grant | 38,000 | $0.00 | |
|
Adhera Therapeutics Inc MRNA
Options to purchase common stock · derivative
|
2015-01-06 | Grant | 38,000 | $0.00 | |
|
Adhera Therapeutics Inc MRNA
Options to purchase common stock · derivative
|
2014-09-15 | Grant | 62,000 | $0.00 | |
|
Adhera Therapeutics Inc MRNA
Common Stock
|
2014-01-01 | Grant | 897,303 |